Because billionaire investors can have a disproportionately large impact on how markets behave in the short term, their buys and sells tend to be closely scrutinized. And controversial hedge-fund manager George Soros is one of the most widely watched superinvestors on Wall Street, stemming from his uncanny ability to build market-crushing portfolios, time and again.
Last week's 13F filings with the SEC gave us an overview of Soros' market activity in the fourth quarter, and the billionaire surprisingly decided to dump three top dividend payers in the healthcare sector. Specifically, he sold off his entire positions in drugmakers AbbVie (NYSE: ABBV) and AstraZeneca plc (NYSE: AZN) and continued slashing his stake in the world's largest generic-drug manufacturer, Teva Pharmaceutical Industries Ltd. (NYSE: TEVA). As dividend stocks are generally viewed as long-term buys given that they generate income, Soros' decision to sell these stocks might be something people view as a major red flag.
Source: Motley Fool
Related Articles:
- 4 Dividend Stocks For A Confident And Secure Future
- High-Yield, High-Return Investments To Increase Income While Waiting On Dividend Growth
- The Most Important Financial Statement When Selecting Dividend Growth Stocks
- 5 Five-Star Dividend Stocks
- 5 Dividend Stocks Delivering The Secret To Successful Investing
________________________________________________________________
Subscribe to:
Post Comments (Atom)
Popular Posts Last 30 Days
-
Today, we’ll look at three high-yield dividend stocks that have earned a ‘perfect 10’ from the Smart Score. For investors seeking a clear fo...
-
Many companies have been suspending their dividends during the COVID-19 crisis, and in many cases it is understandable. In times of economic...
-
While near-term fluctuations in the stock market can be unpredictable, dividends are one of the few reliable sources of market returns. Stoc...
-
“Research shows that dividend cuts are associated with significant share price declines on announcement,” Cornell University Professor of Fi...
-
AbbVie (NASDAQ:ABBV) is in the midst of a transition. AbbVie began life about a decade ago when it was spun off from health care and medical...
-
With interest rates at historic lows and bond-yields heading down quickly, the payouts from dividend stocks are becoming more and more appea...
-
3M Company (NYSE:MMM) is growing its FCF very well, and as a result, MMM stock is likely to move up at least 44% over the next or so. Right ...
-
Dividend investing is a great way for investors to earn reliable income. Dividend stocks tend to have stable, cash-generating business model...
-
Warren Buffett has said the best time to sell is never, and though he often doesn't follow his own rules -- as the recent sale of all th...
-
We’ve pulled up the details on some of Oppenheimer's recommendations. These are stocks with a specific set of clear attributes, that fre...
0 comments
Post a Comment
Post a Comment
Note: Only a member of this blog may post a comment.